Vimarsana
Biggest News Aggregation in the World

Changes Being Effected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Changes Being Effected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Changes Being Effected Today - Breaking & Trending Today

. . . Try, Try Again; But Enough is Enough - Vimarsana News

. . . Try, Try Again; But Enough is Enough

Is what the court finally had to tell plaintiff in Roshkovan v. Bristol-Myers Squibb Co., 2023 U.S. Dist. LEXIS 166742 (C.D. Cal. Sep. 19, 2023) in…

Some Welcome Clarity on Preemption | Reed Smith - Vimarsana News

Some Welcome Clarity on Preemption | Reed Smith

Every once in a while in this space we summarize law review articles. In the course of doing so, we typically pat ourselves on the back by announcing that we read such articles so that...

Lack of "Newly Acquired Information" Defeats Plaintiffs' Claims in Zofran MDL | Faegre Drinker Biddle & Reath LLP - Vimarsana News

Lack of "Newly Acquired Information" Defeats Plaintiffs' Claims in Zofran MDL | Faegre Drinker Biddle & Reath LLP

Zofran (ondansetron) has often been used to combat nausea during pregnancy. It has never been approved by the FDA for that indication, but clinical experience has not supported an...

Court Denies Motion to Dismiss Claims Targeting a Biologic - Vimarsana News

Court Denies Motion to Dismiss Claims Targeting a Biologic

The decision we report on today, Frye v. Novartis Pharms. Corp., 2022 WL 4305656 (E.D. Ark. 2022), leaves us shaking our heads. The court denied the…

FDA issues final guidance for importing drugs prior to anticipated approval | Hogan Lovells - Vimarsana News

FDA issues final guidance for importing drugs prior to anticipated approval | Hogan Lovells

Last week, the U.S. Food and Drug Administration (FDA) published the final guidance, “Pre-Launch Activities Importation Requests (PLAIR),” describing its policy regarding requests for...